Vivos Therapeutics Inc (VVOS)
2.09
+0.14
(+7.18%)
USD |
NASDAQ |
May 31, 16:00
2.07
-0.02
(-0.96%)
After-Hours: 20:00
Vivos Therapeutics Enterprise Value: 4.134M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.134M |
| May 30, 2024 | 3.682M |
| May 29, 2024 | 3.714M |
| May 28, 2024 | 4.070M |
| May 24, 2024 | 4.166M |
| May 23, 2024 | 4.134M |
| May 22, 2024 | 4.263M |
| May 21, 2024 | 4.489M |
| May 20, 2024 | 4.618M |
| May 17, 2024 | 4.780M |
| May 16, 2024 | 4.683M |
| May 15, 2024 | 4.424M |
| May 14, 2024 | 5.425M |
| May 13, 2024 | 3.876M |
| May 10, 2024 | 3.726M |
| May 09, 2024 | 3.920M |
| May 08, 2024 | 4.472M |
| May 07, 2024 | 4.636M |
| May 06, 2024 | 4.487M |
| May 03, 2024 | 5.232M |
| May 02, 2024 | 5.232M |
| May 01, 2024 | 4.946M |
| April 30, 2024 | 4.934M |
| April 29, 2024 | 5.113M |
| April 26, 2024 | 5.113M |
| Date | Value |
|---|---|
| April 25, 2024 | 4.726M |
| April 24, 2024 | 5.054M |
| April 23, 2024 | 5.292M |
| April 22, 2024 | 5.262M |
| April 19, 2024 | 5.501M |
| April 18, 2024 | 5.322M |
| April 17, 2024 | 5.322M |
| April 16, 2024 | 5.441M |
| April 15, 2024 | 5.65M |
| April 12, 2024 | 5.262M |
| April 11, 2024 | 5.560M |
| April 10, 2024 | 5.382M |
| April 09, 2024 | 5.605M |
| April 08, 2024 | 6.425M |
| April 05, 2024 | 6.366M |
| April 04, 2024 | 5.965M |
| April 03, 2024 | 5.610M |
| April 02, 2024 | 6.634M |
| April 01, 2024 | 6.594M |
| March 31, 2024 | 10.58M |
| March 28, 2024 | 11.55M |
| March 27, 2024 | 11.06M |
| March 26, 2024 | 10.57M |
| March 25, 2024 | 6.701M |
| March 22, 2024 | 7.416M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.243M
Minimum
Dec 14 2022
165.76M
Maximum
Dec 17 2020
36.05M
Average
16.29M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Senseonics Holdings Inc | 181.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.763M |
| Revenue (Quarterly) | 3.419M |
| Total Expenses (Quarterly) | 7.204M |
| EPS Diluted (Quarterly) | -1.63 |
| Gross Profit Margin (Quarterly) | 56.65% |
| Profit Margin (Quarterly) | -110.1% |
| Earnings Yield | -523.0% |
| Normalized Earnings Yield | -546.90 |